Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy

Chronic bacterial respiratory-tract infections are a major driving force in the pathogenesis of cystic fibrosis (CF) lung disease and promote chronic lung-function decline, destruction, and progression to respiratory failure at a premature age. Gram-negative bacteria colonizing the airways in CF are...

Descripción completa

Detalles Bibliográficos
Autores principales: Koerner-Rettberg, Cordula, Ballmann, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178503/
https://www.ncbi.nlm.nih.gov/pubmed/25278817
http://dx.doi.org/10.2147/CE.S64980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178503/
https://www.ncbi.nlm.nih.gov/pubmed/25278817
http://dx.doi.org/10.2147/CE.S64980

Ejemplares similares